UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation
- 1 August 1998
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 352 (9125), 343-346
- https://doi.org/10.1016/s0140-6736(97)11280-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Diagnosis of fetal abnormalities at the 10–14‐week scanUltrasound in Obstetrics & Gynecology, 1997
- Increased Nuchal Translucency as a Marker for Fetal Chromosomal DefectsNew England Journal of Medicine, 1997
- Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestationBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- The lambda sign at 10–14 weeks of gestation as a predictor of chorionicity in twin pregnanciesUltrasound in Obstetrics & Gynecology, 1996
- Assessment of fetal anatomy at 12 to 13 weeks of gestation by transabdominal and transvaginal sonographyBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of ageUltrasound in Obstetrics & Gynecology, 1995
- Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucencyUltrasound in Obstetrics & Gynecology, 1995
- The imprecision in rates of down syndrome by 1‐year maternal age intervals: A critical analysis of rates used in biochemical screeningPrenatal Diagnosis, 1994
- First‐trimester diagnosis of nuchal anomalies: significance and fetal outcomeUltrasound in Obstetrics & Gynecology, 1992
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992